Insider Transactions in Q4 2020 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2020
|
Jeffrey Eisele Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,211
+50.0%
|
-
|
|
Dec 15
2020
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.45%
|
$260,000
$52.16 P/Share
|
|
Dec 15
2020
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.37%
|
$130,000
$52.16 P/Share
|
|
Dec 15
2020
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.37%
|
$5,000
$2.67 P/Share
|
|
Dec 14
2020
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
25,000
-4.29%
|
$1,375,000
$55.04 P/Share
|
|
Dec 14
2020
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
8,398
-2.89%
|
$445,094
$53.24 P/Share
|
|
Dec 14
2020
|
David O. Watson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,398
+13.95%
|
$109,174
$13.85 P/Share
|
|
Dec 11
2020
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
9,935
-18.63%
|
$496,750
$50.0 P/Share
|
|
Dec 11
2020
|
David O. Watson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,935
+15.7%
|
$129,155
$13.85 P/Share
|
|
Dec 08
2020
|
Lukas Scheibler Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,482
+26.65%
|
$194,532
$26.73 P/Share
|
|
Dec 07
2020
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
18,564
-4.35%
|
$928,200
$50.71 P/Share
|
|
Dec 04
2020
|
Federico Grossi Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,250
+15.21%
|
$21,750
$3.2 P/Share
|
|
Dec 04
2020
|
Nicole D Perry Vice President - Accounting |
SELL
Open market or private sale
|
Direct |
18,000
-100.0%
|
$900,000
$50.0 P/Share
|
|
Dec 04
2020
|
Nicole D Perry Vice President - Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+50.0%
|
$54,000
$3.76 P/Share
|
|
Dec 04
2020
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
6,436
-1.44%
|
$321,800
$50.55 P/Share
|
|
Dec 01
2020
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
600
-1.78%
|
$28,800
$48.25 P/Share
|
|
Dec 01
2020
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+3.45%
|
$120,000
$3.76 P/Share
|
|
Nov 16
2020
|
Federico Grossi Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+14.55%
|
$17,250
$3.2 P/Share
|
|
Nov 16
2020
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.37%
|
$97,500
$39.38 P/Share
|
|
Nov 16
2020
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.37%
|
$5,000
$2.67 P/Share
|
|
Nov 16
2020
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.46%
|
$195,000
$39.38 P/Share
|
|
Nov 02
2020
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
600
-2.12%
|
$18,600
$31.09 P/Share
|
|
Oct 15
2020
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.46%
|
$170,000
$34.46 P/Share
|
|
Oct 15
2020
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.37%
|
$87,500
$35.0 P/Share
|
|
Oct 15
2020
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.37%
|
$5,000
$2.67 P/Share
|
|
Oct 07
2020
|
Victoria L. Brown Program Team Lead |
SELL
Open market or private sale
|
Direct |
12,000
-76.89%
|
$420,000
$35.0 P/Share
|
|
Oct 07
2020
|
Victoria L. Brown Program Team Lead |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+43.47%
|
$216,000
$18.98 P/Share
|
|
Oct 07
2020
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
7,500
-1.11%
|
$262,500
$35.0 P/Share
|
|
Oct 07
2020
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+1.1%
|
$15,000
$2.67 P/Share
|
|
Oct 01
2020
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
600
-2.07%
|
$18,000
$30.22 P/Share
|